Abstract
There has been a growing interest in the potential of stem cell transplantation as therapy for pediatric brain injuries. Studies in pre-clinical models of pediatric brain injury such as Traumatic Brain Injury (TBI) and neonatal hypoxia-ischemia (HI) have contributed to our understanding of the roles of endogenous stem cells in repair processes and functional recovery following brain injury, and the effects of exogenous stem cell transplantation on recovery from brain injury. Although only a handful of studies have evaluated these effects in models of pediatric TBI, many studies have evaluated stem cell transplantation therapy in models of neonatal HI which has a considerable overlap of injury pathology with pediatric TBI. In this review, we have summarized data on the effects of stem cell treatments on histopathological and functional outcomes in models of pediatric brain injury. Importantly, we have outlined evidence supporting the potential for stem cell transplantation to mitigate pathology of pediatric TBI including neuroinflammation and white matter injury, and challenges that will need to be addressed to incorporate these therapies to improve functional outcomes following pediatric TBI.
Highlights
Traumatic brain injury (TBI) is the leading cause of death and disability among the pediatric population
Stem-cell based therapies can take advantage of the robust proliferative capacity and plasticity in the immature brain, and have potential to become an effective treatment for pediatric TBI
The beneficial effects of exogenous stem cell transplantation have been established in adult TBI and stroke models, additional research is necessary to determine whether these benefits of stem cell therapy translate to pediatric TBI
Summary
Dana Lengel 1, Cruz Sevilla 2, Zoe L. There has been a growing interest in the potential of stem cell transplantation as therapy for pediatric brain injuries. Only a handful of studies have evaluated these effects in models of pediatric TBI, many studies have evaluated stem cell transplantation therapy in models of neonatal HI which has a considerable overlap of injury pathology with pediatric TBI. We have summarized data on the effects of stem cell treatments on histopathological and functional outcomes in models of pediatric brain injury. We have outlined evidence supporting the potential for stem cell transplantation to mitigate pathology of pediatric TBI including neuroinflammation and white matter injury, and challenges that will need to be addressed to incorporate these therapies to improve functional outcomes following pediatric TBI
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have